Navigation Links
Fentora in Medical News

Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA

Cephalon to Hold Conference Call with Investors Today at 5:30 p.m. EDT FRAZER, Pa., May 6 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that a Joint Advisory Committee to the U.S. Food and Drug Administration (FDA) voted not to recommend approval of an expanded label...

Cephalon Reports Strong First Quarter Earnings

... Generic OTFC 27,318 - 27,318 34,020 - 34,020 fentora 38,933 - 38,933 31,690 - 31,690 AMRIX ...24%) Generic OTFC (20%) 0% (20%) fentora 23% 0% 23% AMRIX ...
Fentora in Medical Technology

Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain

FDA Requests Enhancements to Risk Mitigation Strategies Consistent with Company's Recommendations FRAZER, Pa., Sept. 15 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today receipt of a complete response letter from the Food and Drug Administration (FDA...

Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain

Company on Target to File Supplemental New Drug Application in the Fourth Quarter FRAZER, Pa., Aug. 16 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced positive results from a 12-week, Phase 3 clinical trial of FENTORA(R) (fentanyl buccal ta...

Cephalon Presents Positive Results for Fentora in Breakthrough Pain Associated with Neuropathic Conditions

All Efficacy Measures Reached Statistical Significance FRAZER, Pa., May 01, 2007 /PRNewswire-FirstCall/ -- A Cephalon, Inc. Phase 3 clinical trial presented today at the 59th Annual Meeting of the American Academy of Neurology in Boston highlights data demonstrating that FENTORA(R) (fentan...
Fentora in Biological Technology

Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application

FRAZER, Pa., Jan. 25 /PRNewswire-FirstCall/ -- Cephalon, Inc., (Nasdaq: CEPH) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental New Drug Application (sNDA) for FENTORA(R) (fentanyl buccal tablet) [C-II] for the management of breakthrough p...

Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain

Company on Target to File Supplemental New Drug Application in the Fourth Quarter FRAZER, Pa., Aug. 16 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced positive results from a 12-week, Phase 3 clinical trial of FENTORA(R) (fentanyl buccal ta...

Cephalon Submits Supplemental New Drug Application for FENTORA

Indication Sought for Breakthrough Pain Associated with Chronic Pain Conditions in Patients Who are Already Taking Opioid Medications Around-the-Clock FRAZER, Pa., Nov. 12 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced it has submitted a...

Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA

FRAZER, Pa., Sept. 13 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today communicated with healthcare professionals to clarify the appropriate patient selection, dosing and administration for FENTORA(R) (fentanyl buccal tablet) [C-II]. The company is sharing this information with th...

Cephalon's New Product Launches Pace Record 2008 Sales

... - 19,915 31,471 - 31,471 fentora 38,609 - 38,609 33,912 ... Generic OTFC (37) - (37) fentora 14 - 14 AMRIX ...- 95,760 129,033 - 129,033 fentora 155,246 - 155,246 135,136 ...

Cephalon Reports Another Strong Quarter

... 19,569 - 19,569 fentora 41,330 - ... 32,689 - 32,689 fentora 33,193 - ... (40) - (40) fentora 25 - ...

Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008

... - 28,958 30,853 - 30,853 fentora 36,374 - 36,374 36,341 ... (6%) - (6%) fentora 0% - ... - 56,276 64,873 - 64,873 fentora 75,307 - 75,307 68,031 ...

Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals

...04 and 6,974,590 patents do not expire until 2019. fentora was approved by the U.S. Food and Drug Administrat...e United States. Watson alleges that the above two fentora patents are invalid, unenforceable and/or will not...Executive Vice President and General Counsel. "The fentora patents were approved by the United States Patent ...

Cephalon Notified of Generic Fentanyl Buccal Tablet Filing

...sion of FENTORA(R) (fentanyl buccal tablet) [C-II]. In its Notice Letter, Watson alleges that the U.S. Patent Numbers 6,200,604 and 6,974,590 covering fentora are invalid, unenforceable and/or will not be infringed by Watson's manufacture, use or sale of the product described in its ANDA. Cephalon currentl...

Cephalon's 2007 Results Exceed Full Year Sales and Earnings Guidance

... 31,471 - 31,471 fentora 33,912 - 33,91... 46,630 - 46,630 fentora 29,250 - 29,25... (33%) 0% (33%) fentora 16% 0% ...
Other Tags
(Date:8/23/2014)... 2014 Dealing with a drug or alcohol ... the addict is a child. Adolescent addiction has been an ... time, but a new helpline is now providing a valuable ... to find a real addiction recovery center. , The Troubled ... impact in the community. By calling (404) 975-2762, parents and ...
(Date:8/22/2014)... (PRWEB) August 23, 2014 Search ... on the first page of search engines and ... SEO Hosting has recently compared many Linux hosting ... and Bluehost are the most recommended Linux hosting ... Australia and Europe to buy high quality Linux ...
(Date:8/22/2014)... Today, Zane Benefits, the #1 Online Health ... Plans. , According to Zane Benefits, employers are adopting ... the cost of healthcare without reducing coverage for employees. ... can be confusing. , The new guide contains a ... types of ABHPs. It also explains the similarities, ...
(Date:8/22/2014)... 23, 2014 This report studies ... Liquid Handling Systems), Consumables (Tubes), Kits (Isolation, Purification), ... Diagnostics) - Global Forecast to 2018" This market ... is poised to grow at a CAGR of ... million by 2018. , Browse 98 market data ...
(Date:8/22/2014)... Recently, iFitDress.com, a well-known wedding dress manufacturer and ... wedding gowns . In addition to this, the company’s ... are provided with low shipping fees. , He ... new wedding gowns. In our online store, there are ... choose from. What’s more, all of them are extremely ...
Breaking Medicine News(10 mins):Health News:Atlanta’s New Troubled Teen Helpline Is Making a Difference in the Community 2Health News:Top10BestSEOHosting.com Announces Best Cheap Hosting Suppliers Of This Summer 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Discounted Wedding Gowns For Sale At Leading Online Shop iFitDress.com 2
(Date:8/22/2014)... , a leading source of information for businesses and ... California, Riverside in its 2014 list of "some of ... To generate the list, the company analyzed citation data ... work has had enormous impact. , The following UC ... published the greatest number of highly cited papers in ...
(Date:8/22/2014)... August 21, 2014 Diabetes affects nearly 10 ... complaints of diabetics: constant finger pricking to test ... Chemical Biology reports the development of a protein ... accurate results for diabetes patients. In the American ... Daunert, Ph.D., shows off her "designer protein" that ...
(Date:8/22/2014)... and clinical research and technological advances, the fight ... spanning multiple fronts. , Work happening in a ... new and more selective therapies for cancer. Researchers ... enzyme overexpressed in certain cancersand they have tested ... Chemistry professor Christopher Cairo and his team synthesized ...
Breaking Biology News(10 mins):5 UC Riverside scientists among world's most influential scientific minds 2New enzyme targets for selective cancer therapies 2New enzyme targets for selective cancer therapies 3
Other Contents